Study of the use of antidepressants for depression in dementia: the HTA -SADD trial - a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine
Banerjee, S., Hellier, J., Romer, R., Dewey, M., Knapp, M.
, Ballard, C., Baldwin, R., Bentham, P., Fox, C., Holmes, C., +15 more...Katona, C., Livingston, G., Lawton, C., McCrae, N., Moniz-Cook, E., Murray, J., Nurock, J., Orrell, M., O'Brien, J., Poppe, M., Thomas, A., Walwyn, R., Wilson, K., Burns, A. & Lindesay, J.
(2013).
Study of the use of antidepressants for depression in dementia: the HTA -SADD trial - a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine.
Health Technology Assessment,
17(7).
https://doi.org/10.3310/hta17070
, Ballard, C., Baldwin, R., Bentham, P., Fox, C., Holmes, C., +15 more...Katona, C., Livingston, G., Lawton, C., McCrae, N., Moniz-Cook, E., Murray, J., Nurock, J., Orrell, M., O'Brien, J., Poppe, M., Thomas, A., Walwyn, R., Wilson, K., Burns, A. & Lindesay, J.
(2013).
Study of the use of antidepressants for depression in dementia: the HTA -SADD trial - a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine.
Health Technology Assessment,
17(7).
https://doi.org/10.3310/hta17070
Study finds no evidence to support the use of antidepressants as a first-line treatment for people with depression in Alzheimer's disease who are referred to old-age psychiatry services, as many cases will resolve with usual care